about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
3.53
-0.02
(-0.56%)
131.6K
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Genelux Corp is on 01 Aug 2025 for the purpose of Genelux Corp Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..